The acquisition of Cantel Medical by Steris, announced on 12 January, will create a giant medical device sterilization and infection control company. The stock deal values Cantel at around $3.6bn, or $84.66 a share.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?